You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

"Lung[A04.400]"

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

Non-squamous Non-small-cell Lung Cancer Trial in Beijing (SIBP04, Avastin, Paclitaxel)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 7, 2022

Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

Active, not recruiting
  • Lung Cancer
  • La Jolla, California
  • +30 more
Mar 8, 2022

Metastatic Non-squamous Lung Cancer Trial in Villejuif (Pembrolizumab 200 mg Q6W, Pemetrexed 500 mg/m^2 Q3W, Pembrolizumab 200

Not yet recruiting
  • Metastatic Non-squamous Lung Cancer
  • Pembrolizumab 200 mg Q6W
  • +2 more
  • Villejuif, Val-de-Marne, France
    Institut Gustave Roussy
Jan 11, 2023

Carcinoma, Non-Small-Cell Lung Trial in Beijing (HLX10, an engineered anti-PD-1 antibody, HLX04, a bevacizumab biosimilar,

Recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • HLX10, an engineered anti-PD-1 antibody
  • +3 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences (CAMS)
Apr 29, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Locally Advanced or Metastatic NSCLC Trial in Worldwide (Trastuzumab Deruxtecan, Cisplatin, Carboplatin)

Recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Trastuzumab Deruxtecan
  • +4 more
  • Anchorage, Alaska
  • +148 more
Aug 11, 2022

NSCLC Trial in Worldwide (Osimertinib, Cisplatin, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer
  • Birmingham, Alabama
  • +222 more
Dec 7, 2022

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +4 more
  • Santa Ana, California
  • +15 more
Dec 13, 2022

NSCLC, Recurrent NSCLC, Metastatic NSCLC Trial in Worldwide (Nivolumab, Relatlimab, Carboplatin)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +6 more
  • Arcadia, California
  • +149 more
Oct 7, 2022

Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

Terminated
  • Respiratory Syncytial Virus Infections
  • Influenza, Human
  • RSV A Memphis 37
  • Influenza A/California/04/2009
  • London, United Kingdom
    National Heart and Lung Institute, Imperial College London
Jun 23, 2022

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Non Small Cell Lung Cancer Trial in Worldwide (IPH5201 + durvalumab + standard chemo)

Recruiting
  • Non Small Cell Lung Cancer
  • IPH5201 + durvalumab + standard chemotherapy
  • Tampa, Florida
  • +23 more
Feb 23, 2023

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

Small Cell Lung Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +3 more
  • Fort Myers, Florida
  • +113 more
Nov 30, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Dorothy P. and Richard P. Simmons Center for ILD Research

Recruiting
  • Lung Diseases, Interstitial
    • Pittsburgh, Pennsylvania
      Michelle F MacPherson
    Dec 13, 2022

    NSCLC Trial in Worldwide (Durvalumab, Placebo, Carboplatin/Paclitaxel)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Phoenix, Arizona
    • +233 more
    Nov 18, 2022

    NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Santa Monica, California
    • +25 more
    Jun 27, 2022

    NSCLC Trial in Worldwide (Atezolizumab)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Caba, Argentina
    • +111 more
    May 25, 2022

    Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)

    Recruiting
    • Small Cell Lung Carcinoma
    • AMG 757
    • +2 more
    • Duarte, California
    • +34 more
    Dec 6, 2022

    Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

    Recruiting
    • Squamous-Cell Non-Small-Cell Lung Cancer
    • Orange, California
    • +24 more
    Jul 27, 2022

    Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in

    Recruiting
    • Inflammatory Bowel Disease (IBD)
    • +2 more
      • Wroclaw, Dolnoslskie, Poland
      • +10 more
      Sep 12, 2022

      Non Small Cell Lung Cancer (Stage III) Trial in Worldwide (Osimertinib 80mg/40mg, Placebo Osimertinib 80mg/40mg)

      Active, not recruiting
      • Non Small Cell Lung Cancer (Stage III)
      • Osimertinib 80mg/40mg
      • Placebo Osimertinib 80mg/40mg
      • Duarte, California
      • +116 more
      Jan 23, 2023